Bristol-Myers Squibb Company Logo

Bristol-Myers Squibb Company (0R1F)

LSE

Currency in USD
67.25
+0.10 (+0.15%)

Closed

Aug 25, 2026

Day's Range

66.42
68.04

52 wk Range

42.54
71.07

Overview - 0R1F - Bristol-Myers Squibb Company

Key Statistics

Valuation

Enterprise Value

149.31B

P/E (Trailing)

‪18.09‬

PEG Ratio

‪0.11‬

Price / Sales (TTM)

‪3.19‬

Price / Book

‪4.38‬

EV / EBITDA

‪7.98‬

Profitability

Gross Margin

‪71.27%‬

Profit Margin

‪17.62%‬

Operating Margin

‪19.25%‬

Return on Assets

‪5.61%‬

Return on Equity

‪24.66%‬

Ownership

Shares Outstanding

2.04B

Float

2.08B

Held by Insiders

‪0.07%‬

Held by Institutions

‪78.20%‬

Price stats

Beta

‪0.34‬

50-Day Avg

‪60.34‬

200-Day Avg

‪57.45‬

Dividends

Payout Ratio

‪59.84%‬

Frequency

Quarterly

Market Cap - 0R1F - Bristol-Myers Squibb Company

Peers - 0R1F - Bristol-Myers Squibb Company

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on LSE.

Profile Summary - 0R1F - Bristol-Myers Squibb Company

About

Bristol-Myers Squibb Company is a global biopharmaceutical firm founded in 1887 that discovers, develops, licenses, manufactures, markets, distributes, and sells innovative medicines worldwide. Its portfolio addresses critical therapeutic areas including oncology, hematology, immunology, cardiovascular disease,…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees34.30K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.